Before the opening bell, the Nashville-based hospital operator reported adjusted earnings of $1.71 per share, exceeding analysts' expectations of $1.49 per share.
Revenue for the period was $10.26 billion, slightly higher than Wall Street's estimates of $10.24 billion.
Same facility equivalent admissions increased by 1.3% during the period and same facility admissions rose by 1.6%.
Hospital operators have been helped in recent years by a higher number of insured patients under the Affordable Care Act, although analysts have estimated that the benefits to hospitals could moderate, the Wall Street Journal noted.
For 2016, HCA now forecasts earnings per share between $6.20 and $6.65 on revenue of $41.5 billion to $42.5 billion.
Analysts are looking for earnings of $6.27 on revenue of $41.98 billion for the full year.
Separately, TheStreet Ratings Team has a "Buy" rating with a score of B- on the stock.
The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income and revenue growth.
The team believes its strengths outweigh the fact that the company shows weak operating cash flow.
Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
You can view the full analysis from the report here: HCA